Ligand validation:3ODU

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 3ODU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ODU_OLC_B_1601	26%	69%	0.202	0.916	0.55	0.65	-	-	0	0	60%	1
3ODU_OLC_A_1600	22%	67%	0.176	0.84	0.54	0.72	-	-	2	0	72%	1
3ODU_OLC_A_1603	19%	72%	0.222	0.836	0.49	0.58	-	-	3	0	88%	1
3ODU_OLC_B_1602	11%	75%	0.268	0.806	0.45	0.54	-	-	1	0	88%	1
3ODU_OLC_A_1604	10%	67%	0.243	0.814	0.52	0.76	-	-	4	0	64%	1
3OE6_OLC_A_1600	51%	68%	0.132	0.956	0.54	0.68	-	-	1	0	60%	1
9F9J_OLC_A_307	100%	42%	0.034	0.981	1.05	1.18	1	2	0	0	100%	1
7YXA_OLC_A_2505	70%	60%	0.127	0.943	0.67	0.84	-	-	3	0	100%	1
9F9D_OLC_A_308	67%	42%	0.081	0.887	0.96	1.29	1	3	0	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	4	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.